EP3744325

APPLICATION OF NOVEL TYROSINE KINASE INHIBITOR, ANLOTINIB, IN OSTEOSARCOMA AND CHONDROSARCOMA

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    16.1.2019
  • EP published:
    7.6.2023
  • EP application number:
    19740851.1
  • Max expiry date:
    15.1.2039
  • Title in English:
    APPLICATION OF NOVEL TYROSINE KINASE INHIBITOR, ANLOTINIB, IN OSTEOSARCOMA AND CHONDROSARCOMA
  • Language of the patent:
    English

Timeline

Today
16.1.2019EP application
7.6.2023EP Publication

Owner

  • Name:
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
  • Address:
    No. 369 Yuzhou South Road, Lianyungang, Jiangsu 222062, CN

Inventor

  • Name:
    HUA, Yingqi
  • Address:
    Shanghai 200080, CN
  • Name:
    WANG, Gangyang
  • Address:
    Shanghai 200080, CN
  • Name:
    CAI, Zhengdong
  • Address:
    Shanghai 200080, CN
  • Name:
    WANG, Zhuoying
  • Address:
    Shanghai 200080, CN
  • Name:
    ZHANG, Tao
  • Address:
    Shanghai 200080, CN
  • Name:
    WANG, Hongsheng
  • Address:
    Shanghai 200080, CN
  • Name:
    SUN, Mengxiong
  • Address:
    Shanghai 200080, CN
  • Name:
    WANG, Xunqiang
  • Address:
    Lianyungang, Jiangsu 222062, CN
  • Name:
    ZHAN, Xiaole
  • Address:
    Lianyungang, Jiangsu 222062, CN
  • Name:
    YANG, Zhaoqiang
  • Address:
    Lianyungang, Jiangsu 222062, CN
  • Name:
    TU, Lifan
  • Address:
    Lianyungang, Jiangsu 222062, CN
  • Name:
    LI, Pu
  • Address:
    Lianyungang, Jiangsu 222062, CN

Priority

  • Number:
    201810058487
  • Date:
    22.1.2018
  • Country:
    CN

Classification

  • Categories:
    A61K 31/4709, A61P 35/00, A61K 33/243, A61P 35/04

Upload documents